Metabolon Announces Joint Development Agreement with Mayo Clinic to Create New Diagnostic Tests
- Tuesday, August 9, 2022, 7:05
- Finance
- Add a comment
Metabolon and Mayo Clinic will jointly research disease biomarkers and develop novel diagnostic tests for use in Mayo Clinic’s nationwide reference laboratories MORRISVILLE, N.C., Aug. 9, 2022 /PRNewswire/ — Metabolon, Inc., the global leader in metabolomics solutions advancing a wide…
About the Author
adminasapcorp has written 41562 stories on this site.